By bringing its first patch pump to market, Beta Bionics will be able to compete with industry leader Insulet.

Reducing headcount at the Swiss site is part of an ongoing effort to simplify the company’s manufacturing footprint and ...

The separation will allow Medtronic to focus on its cardiovascular, neuroscience and surgical portfolios, CEO Geoff Martha ...

Most medical device manufacturers start their consultation with me asking one of two questions: “Do we need a human factors ...

CEO Mike Mahoney gave more details at a Thursday investor conference, saying the company likely lost orders while its plants ...

Companies including Tempus AI and Updoc are tasked with building an agentic AI system for managing heart failure.

The medtech industry is awaiting FDA guidance on generative AI. The agency has sought feedback in advisory meetings and a ...

Despite making progress restoring global operations, the device maker said in a securities filing that it is unlikely to meet ...

The wearables firm’s sales are growing, and it is adding more paid members, but questions loom about whether the company will ...

CEO Robert Ford has said the atrial fibrillation treatment, along with the company's Volt PFA device, is expected to help ...

Enovis said Tuesday it will buy eCential Robotics for 155 million euros (nearly $180 million) upfront to support development ...

The diabetes tech firm is preparing for the launch of new devices, including a tubeless insulin pump and a fully closed loop ...